Compensation award — excluded from discretionary-purchase analysis.
Traded Nov 25, 2025 · Filed Nov 26, 2025
A board member of Exelixis paid $1.19M out of pocket for Exelixis shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$1,187,235
Shares × reported transaction price
$1M+
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
21 days after results of Nov 4, 2025, 48 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.4% | +0.3% | +0.1% |
| 30 days | +2.7% | +0.7% | +2.1% |
| 90 days | +0.3% | +0.9% | −0.6% |
| 180 days | +13.3% | +9.8% | +3.5% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Officer sold ~$421K of Exelixis
Automatic saleExelixis's Commercial sold $987K of Exelixis shares. Nobody planned it ahead of time.